Key Takeaways For Dentists Weighing Partnership Vs. Solo
- The dental partnership vs. solo private practice decision often hinges on five deal terms: buy-in valuation, compensation formula, decision rights, capital-call obligations, and exit or buy-sell terms. Lifestyle preferences usually play a smaller role than dentists expect.
- Well-structured partnerships can become meaningful wealth-building vehicles. Vague or incomplete agreements can create gridlock, underproduction disputes, and trapped equity with no clean exit path.
- Buy-in valuation methods can vary by buyer type. Doctor-to-doctor deals often use collections multiples, while DSO transactions often use EBITDA multiples. Add-backs can increase normalized earnings by 10–30%, which can significantly change value.
- Compensation formulas in partnerships, whether production-based, ownership-based, or hybrid, can separate take-home pay from pure production. Solo owners keep all profit above expenses but also carry full overhead and business risk.
- McLerran & Associates provides CPA-led, diligence-grade valuations and side-by-side market comparisons that can stand up to buyer review and help dentists structure thoughtful partnerships or exits.
Schedule a free, confidential discovery call with McLerran & Associates.
How Partnership And Solo Ownership Compare In Daily Practice
The table below compares partnership and solo ownership across seven dimensions that often decide the outcome. Focus on where the columns diverge most clearly: control, capital, and exit flexibility. Those areas are where vague agreements can cause the most damage.
| Dimension | Dental Partnership — Pros | Dental Partnership — Cons | Solo Private Practice — Pros / Cons |
|---|---|---|---|
| Control & Autonomy | Shared burden of ownership decisions | Every major decision requires partner alignment; vague agreements create gridlock | Pro: Full clinical and business autonomy. Con: Every decision lands on one person. |
| Overhead & Call Coverage | Overhead split across two or more doctors; shared on-call and coverage | Overhead allocation disputes arise when production is unequal | Pro: No allocation disputes. Con: Full overhead and call burden falls on the owner. |
| Capital Requirements | Buy-in cost is a real upfront or phased financial commitment | Buy-in financing adds debt service that must be modeled against income gain | Pro: No buy-in cost. Con: Full acquisition or startup capital required alone. |
| Decision-Making Speed | Two perspectives can improve major decisions | Unanimous-consent requirements slow structural decisions | Pro: Unilateral speed on all decisions. Con: No check on poor decisions. |
| Income Ceiling | Shared overhead can improve margins; partner production adds practice value | Income depends on the compensation formula in the operating agreement, not just production | Pro: Owner keeps all profit above expenses. Con: Carries all overhead and risk alone. |
| Risk Exposure | Risk shared between partners | Partner underproduction, capital calls, and governance failures create new risks | Pro: No partner-related risk. Con: All business and clinical risk concentrated in one person. |
| Exit Flexibility | A well-drafted buy-sell can create a defined exit path | A poorly drafted buy-sell or none at all can trap a partner with no clean exit | Pro: Owner controls timing and structure of any sale. Con: No built-in succession partner. |
Three of these dimensions deserve extra attention. Overhead allocation, capital requirements, and exit flexibility are where partnerships most often break down and where deal terms carry the most weight.
How A Dental Partnership Buy-In Is Typically Valued
A buy-in price usually starts with a full practice valuation, then gets proportioned by the ownership percentage being acquired. A 30% stake in a practice valued at $900,000 costs $270,000 before any negotiation, so the valuation method behind that $900,000 figure matters a great deal.
Two broad valuation approaches can apply, depending on buyer type. For doctor-to-doctor deals, value is commonly expressed one of two ways: as a percentage of trailing 12-month gross collections, or as a multiple of the seller’s discretionary earnings. Discretionary earnings means the owner’s true economic benefit from the practice, before personal and non-recurring expenses. For general dentistry, the collections-multiple method typically values a practice at 60–75% of annual collections, with overhead, patient retention, and growth trend affecting the exact figure. For DSO and private-equity deals, value is often expressed as a multiple of EBITDA, which stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and reflects cash profitability after normalizing for owner-specific expenses. Single-office practices traded at 4x to 6x EBITDA to dentist-buyers in 2026, while multi-location groups cleared 6x to 8x and platforms above $3 million EBITDA fetched 8x to 11x from growth equity.
Add-backs, which are non-recurring or owner-related expenses removed from reported financials to show normalized earnings, can increase reported EBITDA by 10% to 30% in owner-operated practices. Because that normalized figure is then multiplied, a $50,000 difference in normalized EBITDA becomes $350,000 to $400,000 in deal value at a 7x multiple. That leverage makes a quick, “free” valuation risky, because it can quietly anchor the price and later get re-traded when a buyer’s diligence team reviews the numbers.
Two structural buy-in formats appear most often. An asset buy-in has the incoming partner purchase a defined share of tangible assets and goodwill. An equity buy-in has the incoming partner purchase a percentage of the practice entity itself, which includes goodwill, equipment, and working capital. Phased buy-ins are more common in dental practices. Ownership is acquired in stages, commonly 10–25% increments over 2–5 years, which lets the associate demonstrate production and clinical fit before either party commits to full partnership. Phasing also reduces the associate’s upfront financing burden. The buy-in agreement should specify the valuation method upfront for each tranche so neither side has to renegotiate value at every stage.
McLerran & Associates builds a CPA-led, diligence-grade EBITDA analysis and valuation before any deal goes to market. That level of work helps the number hold up under buyer scrutiny. For owners weighing both the private-buyer and DSO paths, McLerran can deliver a side-by-side valuation that shows the practice’s worth in both markets.
The Compensation Formula And Its Impact On Take-Home Pay
In a dental partnership, take-home pay flows from the compensation formula in the operating agreement. Production still matters, but the formula can change how production turns into income.
A production-based model pays each partner a percentage of their own collections, typically 25% to 35% of collections after lab fees, with shared overhead handled separately. This structure rewards high producers, yet it can create competition over scheduling and patient assignments when production levels diverge.
An ownership-based (equal-draw) model distributes practice profit equally regardless of individual production. This approach can work when partners contribute at similar levels. It often creates friction when one partner consistently outproduces the other or reduces clinical hours without a clear adjustment mechanism.
A hybrid model combines a base salary or draw that covers overhead and administrative time with production-based pay for clinical work above a threshold, plus profit distribution according to equity. Hybrid structures aim to balance fairness and stability when partners have different clinical volumes or are ramping up. They work best when the written terms spell out thresholds, rates, and review points in detail.
For a solo owner, the income picture is simpler and riskier. The owner keeps all profit above expenses and also carries all overhead, debt service, and business risk. A mature, well-run solo practice can pay its owner well above associate median income. A young or heavily leveraged practice can temporarily pay less than an associate salary while the business stabilizes. For deeper analysis of partnership profit-sharing structures, see McLerran’s Best Dental Partnership Profit Sharing Models Explained.
Decision Rights And Governance In A Dental Partnership
Governance problems, rather than clinical disagreements, can be some of the main reasons partnerships fail. Decision-making authority is where many dental partnerships begin to break down quietly, because vague agreements let the most forceful personality decide outcomes instead of a clear process.
A well-drafted operating agreement usually tiers decision rights by financial impact. Structural decisions, such as selling the practice, adding a location, taking on debt above a defined threshold, or entering a long-term affiliation agreement, typically require unanimous consent because each one changes what the partners own. Day-to-day operational decisions, by contrast, can be delegated to a designated managing partner or resolved by simple majority. Hiring staff, approving marketing spend below a threshold, and adjusting scheduling protocols should not require a full partnership vote.
Deadlock provisions play a central role. In a 50/50 partnership, a single standoff between equal partners can freeze the entire enterprise. Deadlock provisions can use a neutral third-party tie-breaker or rotating decision authority, where one partner holds tie-breaking power for clinical decisions while the other controls business operations. Many agreements also require mediation within 30 days of a deadlock, with binding arbitration as the next step if mediation fails.
Core Elements Of A Dental Partnership Buy-Sell Agreement
The buy-sell agreement sets the rules for how a partner exits and on what terms. A well-drafted dental buy-sell agreement usually covers five trigger events: death, total disability, voluntary retirement or exit, involuntary exit, and deadlock. Involuntary exit can include loss of dental license, personal bankruptcy, divorce that exposes practice equity to a non-dentist spouse, or criminal conviction.
The valuation method needs to appear clearly in the document. Three approaches show up most often: a fixed price, a formula such as a collections multiple adjusted by EBITDA margin, and a certified appraisal. A fixed price is simple but can become stale quickly. A formula can auto-adjust but may drift away from real market conditions. A certified appraisal is usually most accurate but slower and more expensive. Many dental attorneys recommend a hybrid approach, with a formula baseline and a right for either partner to request a formal appraisal within 30 days if they dispute the formula result.
Buyout payment terms can matter as much as valuation. Buy-sell provisions often define payment as a 20–30% down payment with the balance paid over 3–5 years at a defined interest rate. The disability trigger deserves close attention. Dentists are 3–4 times more likely to be disabled during their career than to die during it, so the disability clause can be the most important provision for many practitioners.
The buy-sell agreement also needs funding. Life insurance typically funds the death trigger, and disability buyout insurance funds the disability trigger. An unfunded agreement often leaves the surviving partner without a practical way to complete the buyout. For deeper coverage of exit structures, see McLerran’s Dental Partnership Exit Strategies and Typical Dental Partnership Buyout Terms.
Find out what your practice is really worth — request a comprehensive practice valuation.
How Career Stage Shapes The Partnership Vs. Solo Choice
The five deal terms above can matter differently at each career stage. Three common profiles show how the same terms play out for different dentists.
New graduate. A new graduate is often capital-constrained and may carry $200,000 to $300,000 in student debt per American Dental Education Association data. An associate-to-partnership track or a phased buy-in can reduce upfront financing pressure and allow production history to build before full ownership. Solo startup or full acquisition can still work but requires careful modeling of debt service against a realistic ramp-up income curve. The partnership path tends to make sense here only when the buy-in valuation, compensation formula, and governance terms appear clearly in writing.
Mid-career associate holding a buy-in offer. This profile often sits at the center of buy-in discussions. Key questions include whether the buy-in price reflects a defensible, independently verified valuation, whether the compensation formula changes take-home pay enough to justify the buy-in cost and debt service, and whether the operating agreement grants governance rights that match the ownership percentage. A common failure mode is buying into a practice at a valuation set by senior partners years earlier, with no independent appraisal and no honest cash-flow model after debt service. Another frequent issue is buying equity that carries little real decision-making power.
Established solo owner. An established owner deciding whether to take a partner, sell to a private buyer, or affiliate with a DSO often benefits from a side-by-side valuation that quantifies the practice’s worth in both the private-buyer and DSO markets before choosing a path. Owners in the $1.5 million to $3 million revenue range can sometimes pursue either direction. The better answer can depend on practice size, profitability, specialty, and the owner’s personal goals.
When Solo Ownership Makes More Sense Than Partnership
Industry observers note that dental partnerships can fail at higher rates than solo practices. After 15 years of ownership only around 2% of dental practices fail, yet industry experts indicate that between 50% and 80% of dental partnerships fail. The main failure modes are specific and often preventable.
Gridlock on capital calls. When a practice needs more money for equipment, expansion, or a new location and the operating agreement is silent on capital contributions, partners with different risk tolerances or liquidity positions can reach a stalemate. Clear capital-call provisions can help, including what triggers a call, how much each partner must contribute, and what happens if a partner cannot or will not fund their share.
Partner underproduction relative to ownership share. A partner who owns 50% but produces 30% of total collections creates both an overhead allocation issue and a compensation issue. A compensation model that ties pay to individual production, plus a defined review cycle, can reduce this risk. When production levels diverge by more than 20% for two consecutive quarters, many advisors suggest revisiting the partnership structure before resentment hardens into conflict.
Deadlock on major decisions. Equal voting rights without a tie-breaking mechanism can stall decisions about expansion, associate hiring, equipment purchases, and affiliation. Tiered decision rights and a defined deadlock-resolution path, such as mediation followed by binding arbitration, can keep the practice moving.
Unclear exit terms. A partner who wants out and finds no defined valuation method, payment timeline, or buy-sell trigger faces a negotiation under pressure. Partnerships often feel easy to start when everyone is optimistic, and the agreement proves its value when circumstances change.
Solo ownership tends to be the better fit when a dentist values decision speed, wants full control of clinical and business choices, cannot find a partner whose capital, work ethic, and vision align, or runs a practice too small to support two full-time doctors. Partnerships that endure often share several traits: clear operational authority for one partner, genuine philosophical alignment on clinical standards and growth, negotiated exit terms before the partnership begins, and independent legal counsel for each partner.
Frequently Asked Questions (FAQ)
How Do I Know If My Buy-In Price Is Fair?
A fair buy-in price usually traces back to a full practice valuation that matches the ownership percentage being acquired. The key questions involve which valuation method was used, how add-backs were handled, and whether an independent party verified the analysis. Phased buy-ins work best when the valuation method for each stage appears in the agreement from the start.
What Should A Dental Partnership Buy-Sell Agreement Cover?
A dental partnership buy-sell agreement typically defines the trigger events that activate a buyout, the valuation method, the payment terms, and how the agreement will be funded. Many agreements use a formula baseline with an option to request a formal appraisal if either partner disputes the result. Life and disability insurance often fund the buyout so the remaining partner can complete the purchase when a trigger event occurs.
How Does Partner Compensation Differ From Solo Take-Home?
A solo owner keeps all profit above expenses and carries all overhead, debt, and business risk. A partner’s take-home depends on the compensation formula in the operating agreement, which may be production-based, ownership-based, or hybrid. In production-based models, partners receive a percentage of their own collections with overhead handled separately, so income can diverge even at equal ownership. In equal-draw models, profit is split regardless of production, which can create tension when production levels differ.
What Happens If A Partner Wants To Exit?
The buy-sell agreement usually controls the process. It can define which events trigger a buyout, how the departing partner’s interest will be valued, the payment schedule and interest rate, and any right of first refusal for the remaining partner. Without a clear buy-sell, both sides may face a difficult negotiation without a shared framework.
Is Partnership Or Solo Ownership Better For A New Graduate?
New graduates often benefit from a phased buy-in or associate-to-partnership track because these paths reduce upfront financing needs and allow time to build production history. The structure tends to work best when the buy-in valuation is independently verified, the compensation formula is clear, and governance rights match the ownership percentage. Solo startup or full acquisition can still be viable but usually requires careful modeling of debt service against expected ramp-up income.
Conclusion: Use A Real Valuation To Choose Your Path
A dental partnership depends heavily on both the partner and the paperwork. The five deal terms that shape success, including buy-in valuation, compensation formula, decision rights, capital-call obligations, and exit or buy-sell terms, deserve careful attention and a defensible valuation before anyone signs.
Career stage also influences the right answer. A new graduate considering a phased buy-in, a mid-career associate holding a buy-in offer, and an established solo owner weighing partnership, private sale, or DSO affiliation each face a different version of the same decision. Each situation benefits from a valuation grounded in data rather than a quick estimate.
McLerran & Associates is a dental-only, sell-side advisor and advocate that has guided dentists through roughly 2,000 successful practice sales and approximately $2 billion in closed transaction volume over about 35 years. The firm’s CPA-led, diligence-grade EBITDA analysis is designed to hold up under buyer scrutiny, and its clients transact at roughly 85–90%, compared to an industry norm closer to 35–40%.
For owners who have not yet chosen a path, the McLerran M&A Summit (October 29–30, 2026, Austin) offers a way to learn in a low-pressure setting, with 4 CE credits and a complimentary $2,500 practice valuation for attendees.
Talk through your buy-in or exit options with a dental-only advisor.
Join the McLerran M&A Summit, October 29–30, 2026, Austin.
